You are here

Novartis

New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet

Fierce Pharma

Mon, 08/7/17 - 01:32 pm

Gilead Could Be Making An Acquisition — But It's Not What You Think

Investors Business Daily

Fri, 08/4/17 - 11:56 am

Gilead Sciences

United Therapeutics

Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech

Endpoints

Thu, 08/3/17 - 11:06 am

drug manufacturing

Moderna Therapeutics

Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race

Endpoints

Mon, 07/31/17 - 09:57 am

axicabtagene ciloleucel

Amgen And Novartis: First Mover Advantage Is A Must

Seeking Alpha

Mon, 07/24/17 - 11:55 pm

EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda

RAPS.org

Sat, 07/22/17 - 12:23 pm

Lexicon Pharmaceuticals

Drugmakers face challenges marketing new heart drugs

Medical Marketing and Media

Sat, 07/22/17 - 10:01 am

Biotechs Find Strength In Numbers In Treating Multiple Sclerosis

Investors Business Daily

Fri, 07/21/17 - 10:25 am

multiple sclerosis

Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK

Endpoints

Thu, 07/20/17 - 11:34 pm

With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round

Endpoints

Thu, 07/20/17 - 10:47 am

Biotech M&A? Novartis chief Jimenez says he’s sticking to the under-$1B aisle for now

Endpoints

Wed, 07/19/17 - 10:29 am

CAR-T Cell Therapy Is Here To Stay

Forbes

Wed, 07/19/17 - 09:40 am

Novartis sales down -2% but ahead of estimates in Q2

Drug Delivery Business News

Tue, 07/18/17 - 10:46 pm

Novartis unit Alcon posts modest Q2 gain

Mass Device

Tue, 07/18/17 - 09:49 am

Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter

Motley Fool

Sun, 07/16/17 - 03:49 pm

How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals

Investors Business Daily

Fri, 07/14/17 - 08:07 am

Novartis stocks drug cabinet with "Big-3" arthritis blockbusters

Yahoo/Reuters

Fri, 07/14/17 - 07:58 am

rheumatoid arthritis

Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med

Fierce Pharma

Wed, 07/12/17 - 04:29 pm

advisory panels

D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T

Endpoints

Wed, 07/12/17 - 11:00 am

Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod

Fierce Pharma

Tue, 07/11/17 - 09:56 am

Pages